ECP
GBT

Elk Creek Partners’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Elk Creek Partners’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$5.05M Buy
98,767
+16,008
+19% +$1.07M 0.87% 51
2019
Q4 		$6.58M Buy
+82,759
New +$4.9M 0.76% 62

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Elk Creek Partners's GBT Position: Q1 2020 in Review

Elk Creek Partners increased its Global Blood Therapeutics, Inc. (GBT) stake by 19% in Q1 2020, buying an estimated $1.07M and bringing the position to 98,767 shares worth $5.05M. The position accounts for 0.87% of the portfolio, ranked #51.

Elk Creek Partners first reported a position in GBT in Q4 2019 and has held it in 2 quarters since. The position peaked at $6.58M in Q4 2019. 220 funds tracked by Wall St. Rank hold GBT as of Q1 2020.

  • Elk Creek Partners held 98,767 shares of Global Blood Therapeutics, Inc. worth $5.05M as of Q1 2020.
  • Elk Creek Partners bought 16,008 Global Blood Therapeutics, Inc. shares in Q1 2020, an estimated $1.07M.
  • Global Blood Therapeutics, Inc. made up 0.87% of Elk Creek Partners's portfolio in Q1 2020, its #51 holding.
  • Elk Creek Partners first reported a position in Global Blood Therapeutics, Inc. in Q4 2019 and has held it in 2 quarters since.
  • Elk Creek Partners's Global Blood Therapeutics, Inc. position peaked at $6.58M in Q4 2019.
  • 220 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q1 2020.

Based on Elk Creek Partners's 13F filing for Q1 2020, filed 14 May 2020.